DOW LOHNES GOVERNMENT STRATEGIES LLC for AMERISOURCEBERGEN CORPORATION
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Legislative proposals related to prompt pay discounts for drugs and biologicals under Medicare Part B, including S. 733 and H.R. 905; federal policy regarding proposed changes to Medicare drug reimbursement average sales price (ASP) formula; ASP generally (in the context of Deficit Reduction).
| Lobbyist | Covered position, as disclosed |
|---|---|
| M KENNETH BOWLER | — |
| NORMAN LENT | — |
| KENNETH D SALOMON | — |
| MICHAEL SCRIVNER | Chief of Staff, Hon. Norman F. Lent, Jr. |
Taxation/Internal Revenue Code TAX
Legislative proposals to amend the Internal Revenue Code, provisions related to the last-in-first-out inventory accounting method, including the President's proposed FY 2013 budget, S. 89, and S. 164.
| Lobbyist | Covered position, as disclosed |
|---|---|
| M KENNETH BOWLER | — |
| MICHAEL SCRIVNER | Chief of Staff, Hon. Norman F. Lent, Jr. |
Pharmacy PHA
Legislative proposals related to pharmaceutical pedigree anti-counterfeiting, wholesale transaction documentation, and electronic tracking, including H.R. 1483, H.R. 3026, and S. 1584; legislative proposals related to drug shortages, including H.R. 2245 and S. 296.
| Lobbyist | Covered position, as disclosed |
|---|---|
| M KENNETH BOWLER | — |
| ERIC S KESSLER | Chief of Staff, Hon. John D. Dingell |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.